ACLX (ACLX)
Arcellx, Inc.
NASDAQ:ACLXHealthcare · Biotechnology
Mkt Cap-
Float41.8M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$22.29M
Net Income-$228.93M
Total Assets$603.99M
Free Cash Flow-$212.59M
Debt & Equity
Debt 19%
Equity 81%
Total Debt$96.26M
Total Equity$402.35M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ACLX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$603.99M
Liabilities$201.64M
Accounts Receivable$3.6M
Accounts Payable$5.58M
Inventory$0
PP&E (Net)$66.47M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $22.29M | $107.94M | $110.32M | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -79.4% | -2.2% | - | - | - | - | - | - |
| Cost of Revenue | $6.68M | $5.19M | $0 | $2.22M | $0 | $0 | $326K | $0 |
| Gross Profit | $15.61M | $102.75M | $110.32M | -$2.22M | $0 | $0 | -$326K | $0 |
| Gross Margin | 70.0% | 95.2% | 100.0% | - | - | - | - | - |
| Research and Development | $157.61M | $157.09M | $133.85M | $149.56M | $46.88M | $25.06M | $15.77M | $6.11M |
| Selling, General, and Administrative | $117.76M | $88.41M | $66.35M | $41.7M | $18.14M | $7.04M | $2.21M | $2.2M |
| Other | -$6.68M | -$5.19M | $0 | -$2.22M | $0 | -$1 | $0 | $0 |
| Total Operating Expenses | $268.69M | $240.32M | $200.2M | $189.03M | $65.02M | $32.1M | $17.97M | $8.31M |
| Operating Income (EBIT) | -$253.08M | -$137.57M | -$89.88M | -$191.26M | -$65.02M | -$32.1M | -$17.97M | -$8.31M |
| Operating Margin | -1135.6% | -127.5% | -81.5% | - | - | - | - | - |
| Interest Expense | $24.22M | $1.03M | $3.84M | $1.72M | $10K | $0 | $0 | $0 |
| Interest Income | $0 | $33.32M | $23.7M | $4.3M | $300K | $1K | $0 | $0 |
| Other Income (Expense) | $24.22M | $32.29M | $19.85M | $2.58M | $49K | $999 | $2K | $999 |
| Income Before Tax (EBT) | -$228.87M | -$105.28M | -$70.03M | -$188.68M | -$64.97M | -$32.09M | -$17.97M | -$8.31M |
| Income Tax Expense | $69K | $2.07M | $663K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$228.93M | -$107.35M | -$70.69M | -$188.68M | -$64.97M | -$32.09M | -$17.97M | -$8.31M |
| Net Income Margin | -1027.3% | -99.5% | -64.1% | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -4.07 | -2.00 | -1.47 | -4.28 | -1.94 | -1.47 | -0.52 | -50.17 |
| Diluted EPS | -4.07 | -2.00 | -1.47 | -4.28 | -1.94 | -1.47 | -0.52 | -50.17 |
| Weighted Average OS | 56.31M | 53.57M | 48.06M | 44.11M | 33.54M | 21.78M | 34.78M | 165,581 |
| EBITDA | -$197.97M | -$99.06M | -$64.14M | -$185.64M | -$63.92M | -$31.47M | -$17.65M | -$8.22M |
| EBITDA Margin | -888.3% | -91.8% | -58.1% | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $80.26M | $105.68M | $394.58M | $64.18M | $30.83M | $46.6M | $34.58M | $14.53M |
| Short-Term Investments | $370.07M | $481.7M | $307.43M | $190.66M | $73.78M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $450.33M | $587.38M | $702.02M | $254.84M | $104.62M | $46.6M | $34.58M | $14.53M |
| Accounts Receivable | $3.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $8.25M | $6.05M | $7.58M | $3.67M | $2.05M | $1.21M | $621K | $99K |
| Total Current Assets | $462.18M | $599.31M | $716.36M | $266.86M | $112.81M | $49.36M | $38.07M | $14.63M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $66.47M | $70.25M | $69.83M | $39.89M | $10.32M | $4.9M | $4.33M | $817K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $69.72M | $38.28M | $27.17M | $0 | $0 | $199K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $5.62M | $3.5M | $11.77M | $7.06M | $5.66M | $3.24M | $1.19M | $366K |
| Total Long-Term Assets | $141.81M | $112.02M | $108.77M | $46.95M | $15.97M | $8.34M | $5.52M | $1.18M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $603.99M | $711.33M | $825.13M | $313.82M | $128.78M | $57.69M | $43.59M | $15.81M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $5.58M | $2.1M | $2.62M | $9.05M | $1.33M | $504K | $1.75M | $1.05M |
| Short-Term Debt | $7.58M | $0 | $0 | $0 | $100K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $59.06M | $50.53M | $0 | $183K | $0 | $0 | $0 |
| Other Current Liabilities | $91.05M | $18.97M | $13.74M | $8.48M | $9.46M | $3.4M | $1.05M | $766K |
| Total Current Liabilities | $104.2M | $125.41M | $118.24M | $56.69M | $14.85M | $5.27M | $3.04M | $1.82M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $44.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $53.1M | $76M | $170.67M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$44.34M | $8.59M | $0 | $0 | $235.45M | $1.88M | $73.29M | $0 |
| Total Long-Term Liabilities | $97.44M | $131.13M | $221.51M | $52.17M | $235.45M | $1.88M | $73.29M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $201.64M | $256.54M | $339.75M | $108.86M | $250.3M | $7.15M | $76.33M | $1.82M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $114.26M | $0 | $28.89M |
| Common Stock | $56K | $53K | $52K | $44K | $1K | $2K | $1K | $1K |
| Retained Earnings | -$725.76M | -$496.83M | -$389.48M | -$318.79M | -$130.11M | -$65.14M | -$33.05M | -$15.07M |
| Comprehensive Income & Other | $843K | $848K | $547K | -$221K | -$20K | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.13B | $951.57M | $874.81M | $523.7M | $8.6M | $115.68M | $308K | $29.03M |
| Total Equity | $402.35M | $454.79M | $485.38M | $204.95M | -$121.52M | $50.54M | -$32.74M | $13.96M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $603.99M | $711.33M | $825.13M | $313.82M | $128.78M | $57.69M | $43.59M | $15.78M |
| Supplementary Data | ||||||||
| Total Debt | $96.26M | $54.08M | $97.63M | $88.13M | $100K | $0 | $0 | $0 |
| Net Debt | $16M | -$51.6M | -$296.96M | $23.95M | -$30.73M | -$46.6M | -$34.58M | -$14.53M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$228.93M | -$107.35M | -$70.69M | -$188.68M | -$64.97M | -$32.09M | -$17.97M | -$8.31M |
| Depreciation & Amortization | $6.68M | $5.19M | $2.04M | $1.32M | $1.04M | $629K | $326K | $93K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $77.89M | $61.09M | $41.79M | $21.54M | $6.75M | $1.05M | $136K | $66K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $2.66M | -$70K | -$6.47M | $7.42M | $974K | -$1.33M | $688K | $0 |
| Other Working Capital | -$60.16M | -$30.71M | $231.9M | -$2.97M | $1.75M | $3.09M | -$1.95M | $432K |
| Total Working Capital Change | -$57.49M | -$30.78M | $225.43M | $4.45M | $2.72M | $1.75M | -$1.26M | $432K |
| Other Non-Cash Items | -$8.4M | -$11.62M | $9.01M | $62.06M | $213K | $0 | $0 | $856K |
| Net Cash from Operating | -$210.26M | -$83.47M | $207.57M | -$99.3M | -$54.24M | -$28.66M | -$18.77M | -$6.86M |
| Investing Activities | ||||||||
| Capital Expenditures | -$2.33M | -$13.43M | -$21.43M | -$2.28M | -$5.78M | -$888K | -$3.83M | -$479K |
| Acquisitions | $0 | $0 | $0 | $115.4M | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$406.98M | -$597.31M | -$442.43M | -$273.74M | -$74.19M | $0 | $0 | $0 |
| Sales of Investments | $495.6M | $427.7M | $309.35M | $158.34M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$115.4M | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $86.3M | -$183.04M | -$154.51M | -$117.67M | -$79.98M | -$888K | -$3.83M | -$479K |
| Financing Activities | ||||||||
| Debt Repaid | $230K | $39.85M | $29.39M | $9.68M | $387K | - | - | - |
| Common Stock Issuance | $137.19M | $15.76M | $299.71M | $259.83M | $432K | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$24K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$38.42M | $0 | $8.85M | $2.47M | -$688K | -$1.15M | $86K | $12.48M |
| Net Cash from Financing | $98.53M | -$24.09M | $279.16M | $252.63M | $118.45M | $41.66M | $42.65M | $12.48M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$25.43M | -$290.6M | $332.22M | $35.65M | -$15.76M | $12.11M | $20.05M | $5.14M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$210.26M | -$83.47M | $207.57M | -$99.3M | -$54.24M | -$28.66M | -$18.77M | -$6.86M |
| Capital Expenditure | -$2.33M | -$13.43M | -$21.43M | -$2.28M | -$5.78M | -$888K | -$3.83M | -$479K |
| Free Cash Flow | -$212.59M | -$96.9M | $186.15M | -$101.58M | -$60.02M | -$29.55M | -$22.6M | -$7.34M |
| Cash at Beginning | $108.31M | $398.9M | $66.68M | $31.03M | $46.8M | $34.69M | $14.64M | $9.5M |
| Cash at End | $82.88M | $108.31M | $398.9M | $66.68M | $31.03M | $46.8M | $34.69M | $14.64M |